ERCC overexpression associated with a poor response of cT4b colorectal cancer with FOLFOX-based neoadjuvant concurrent chemoradiation

Colorectal cancer (CRC) of the clinical tumor stage T4b (cT4b) refers to advanced tumors with direct invasion of adjacent structures and the tumors are considered unresectable. Despite advancements in aggressive surgery and combination chemotherapy, the prognosis of cT4b CRC remains poor. Optimizing...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ming-Yii, Lee, Hsin-Hua, Huang, Ching-Wen, Huang, Chun-Ming, Ma, Cheng-Jen, Yin, Tzu-Chieh, Tsai, Hsiang-Lin, Chai, Chee-Yin, Chen, Yi-Ting, Wang, Jaw-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491057/
https://www.ncbi.nlm.nih.gov/pubmed/32963618
http://dx.doi.org/10.3892/ol.2020.12075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491057/
https://www.ncbi.nlm.nih.gov/pubmed/32963618
http://dx.doi.org/10.3892/ol.2020.12075

Ejemplares similares